HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

KUL7211

a beta-adrenoceptor agonist; structure in first source

Also Known As:

2-(4-(2-((2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl)amin) ethyl)phenyloxy)acetic acid; KUL-7211

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acetates: 4994
      - KUL7211: 3
Lipids: 114793
- Fatty Acids: 27405
  - Volatile Fatty Acids: 3052
    - Acetates: 4994
      - KUL7211: 3

Experts

1.	Kojima, Masami: 3 articles (05/2011 - 08/2003)
2.	Tomiyama, Yoshitaka: 3 articles (05/2011 - 08/2003)
3.	Yamazaki, Yoshinobu: 3 articles (05/2011 - 08/2003)
4.	Wanajo, Isao: 2 articles (05/2011 - 12/2005)
5.	Shibata, Nobuo: 2 articles (12/2005 - 08/2003)
6.	Kobayashi, Mamoru: 1 article (12/2005)
7.	Tadachi, Mariko: 1 article (12/2005)
8.	Akahane, Masuo: 1 article (08/2003)
9.	Akiyama, Katsuyoshi: 1 article (08/2003)
10.	Hayakawa, Kohichi: 1 article (08/2003)

Related Diseases

1.	Ureteral Obstruction 05/01/2011 - "In the anesthetized pigs, all 4 drugs reduced the unilateral ureteral obstruction-induced elevated intraureteral pressure in a dose-dependent manner, with KUL-7211 reducing it with a lower hypotensive effect than either isoproterenol or terbutaline. " 05/01/2011 - "To compare the potency and ureteral selectivity of the selective β(2)/β(3)-adrenoceptor agonist KUL-7211 with those of the nonselective β-adrenoceptor agonist isoproterenol, selective β(2)-adrenoceptor agonist terbutaline, and selective β(3)-adrenoceptor agonist CL-316243, we performed the study using an isolated porcine ureter and a porcine model of acute unilateral ureteral obstruction. " 05/01/2011 - "Ureteral selectivity of intravenous β-adrenoceptor agonists in pig model of acute ureteral obstruction: comparison of KUL-7211, a selective β2/β3 agonist, with isoproterenol, terbutaline, and CL-316243."
2.	Urolithiasis 12/01/2005 - "Possibly, KUL-7211 might be useful for promoting stone passage and relieving ureteral colic in urolithiasis patients." 08/01/2003 - "KUL-7211 may be a novel and useful medication for relieving ureteral colic and promoting stone passage in urolithiasis patients." 05/01/2011 - "A selective β(2)/β(3)-adrenoceptor agonist, such as KUL-7211, warrants additional investigation as a potentially useful drug for the promotion of stone passage in patients with urolithiasis."
3.	Renal Colic 12/01/2005 - "Possibly, KUL-7211 might be useful for promoting stone passage and relieving ureteral colic in urolithiasis patients." 08/01/2003 - "KUL-7211 may be a novel and useful medication for relieving ureteral colic and promoting stone passage in urolithiasis patients."

Related Drugs and Biologics

1.	Terbutaline (Brethaire)
2.	Adrenergic Receptors (Adrenergic Receptor)
3.	Isoproterenol (Isoprenaline)
4.	disodium (R,R)- 5- (2- ((2- (3- chlorophenyl)- 2- hydroxyethyl)- amino)propyl)- 1,3- benzodioxole- 2,3- dicarboxylate